Functional Food

This hub provides a comprehensive overview and the latest news on functional foods, superfoods, and dietary components that contribute to health and disease prevention. The collection highlights bioactive compounds in foods such as lychee, chia seeds, dates, baobab fruit, and black sesame, alongside evidence-based discussions on fermented foods, postbiotics, and algae-based supplements. Readers will also find insights into the health benefits of traditional and modern diets, including the Atlantic and Washoku patterns, as well as functional beverages and plant-derived oils. By combining nutritional science, clinical research, and updates on emerging food innovations, this hub equips healthcare professionals, researchers, and health-conscious individuals with reliable knowledge to evaluate functional foods and their role in supporting long-term wellness. https://www.news-medical.net/condition/Functional-Food

Novogene Europe launches Untargeted Metabolomics Service at Cambridge Omics Centre

https://www.news-medical.net/news/20260713/Novogene-Europe-launches-Untargeted-Metabolomics-Service-at-Cambridge-Omics-Centre.aspx Novogene Europe, a multiomics research services partner, today announced that it has strengthened its position as a multiomics partner with the launch of its Untargeted Metabolomics Service through its Cambridge Omics Centre. This new capability will help researchers across the UK and Europe to connect molecular data with biological function by adding metabolite-level insight to genomics, transcriptomics, microbiome and broader life science studies.

Blocking ZFP384 protein extends brain repair window after stroke

https://www.news-medical.net/news/20260713/Blocking-ZFP384-protein-extends-brain-repair-window-after-stroke.aspx Blocking the activity of ZFP384 can prolong the brain’s endogenous repair functions after stroke, report researchers in a collaborative study. They developed an antisense oligonucleotide-based therapy that sustained the reparative activity of microglia by promoting remyelination and neural plasticity, thereby improving functional recovery in mice. Surprisingly, these results were observed even when the treatment began weeks after injury. The findings reveal a promising strategy to extend the brain’s recovery window after stroke, improving long-term outcomes.

Rising tick-borne disease in Canada can trigger heart inflammation

https://www.news-medical.net/news/20260713/Rising-tick-borne-disease-in-Canada-can-trigger-heart-inflammation.aspx Move over, Lyme disease - there's another tick-borne disease to worry about in Canada. Anaplasmosis, the second most common tick-borne disease in the country, can cause a range of health issues, including myocarditis (inflammation of the heart muscle). "As the incidence of tick-borne diseases rises rapidly across Canada … considering anaplasmosis as a possible pathogen is increasingly important for front-line clinicians," writes Dr. Michael Quon, a general internal medicine specialist and clinician investigator at The Ottawa Hospital, and an assistant professor, University of Ottawa, Ottawa, Ontario, with coauthors.

Study reveals substantial rise in Latin American dementia rates

https://www.news-medical.net/news/20260713/Study-reveals-substantial-rise-in-Latin-American-dementia-rates.aspx A new study led by researchers at Washington University School of Medicine in St. Louis and Newcastle University in the U.K. finds that the share of adults living with dementia rose substantially across several Latin American and Caribbean sites over the past two decades. The research provides the first direct evidence that some parts of Latin America are moving in the opposite direction of dropping dementia rates in the U.S. and other wealthy nations.

Study links GLP-1 treatment to fewer alcohol drinking days

https://www.news-medical.net/news/20260713/Study-links-GLP-1-treatment-to-fewer-alcohol-drinking-days.aspx A large 'All of Us' analysis suggests people with current GLP-1 prescriptions drink less often, although the observational findings do not prove that the drugs reduce alcohol use. In a recent study published in the journal Alcohol: Clinical and Experimental Research, researchers examined whether recorded prescriptions for glucagon-like peptide-1 receptor agonists (GLP-1RAs) are associated with self-reported alcohol consumption among participants in the National Institutes of Health's (NIH’s) All of Us Research Program.

Epcoritamab monotherapy or epcoritamab with lenalidomide as first-line therapy for patients with diffuse large B-cell lymphoma (EPCORE DLBCL-3): primary analysis of an open-label, multicentre, randomised, phase 2 trial Prof Umberto Vitolo, MDa Send email to umberto.vitolo@ircc.it ∙ Juan Miguel Bergua Burgues, MDb ∙ Johannes Duell, MDc ∙ Michal Kwiatek, MDd ∙ David Belada, MD PhDe ∙ Wojciech Jurczak, MD PhDf ∙ et al.

Epcoritamab monotherapy or epcoritamab with lenalidomide as first-line therapy for patients with diffuse large B-cell lymphoma (EPCORE DLBCL-3): primary analysis of an open-label, multicentre, randomised, phase 2 trial Prof Umberto Vitolo, MDa Send email to umberto.vitolo@ircc.it ∙ Juan Miguel Bergua Burgues, MDb ∙ Johannes Duell, MDc ∙ Michal Kwiatek, MDd ∙ David Belada, MD PhDe ∙ Wojciech Jurczak, MD PhDf ∙ et al. https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00112-2/abstract?utm_campaign=update-lanhae&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanhae&_hsenc=p2ANqtz-9FnJ5j5Y6Y-nDJsIE9y3t_mYxrsI9cVpsk2TSB-EgXrObaDC0p8hSZ5eksJX5NUke7pQxmH1CpDAAahWPm1eOSV1gPZQ&_hsmi=428051533&utm_content=427687149&utm_source=hs_email